000 02670cam  2200373zi 4500
0019.933486
003CaOODSP
00520240313114215
006m     o  d f      
007cr cn|||||||||
008240205e201803##onca    ob   f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP5-210/2018E-PDF
24500|aEvaluation of healthcare-associated infection activities at the Public Health Agency of Canada 2012-13 to 2016-17 / |cprepared by Office of Audit and Evaluation, Health Canada and the Public Health Agency of Canada.
24617|aEvaluation of the healthcare-associated infection activities at PHAC
264 1|a[Ottawa] : |bHealth Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, |cMarch 2018.
300 |a1 online resource (viii, 38 pages) : |billustrations
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aCover title.
500 |aIssued also in French under title: Évaluation des activités visant les infections associées aux soins de santé à l'Agence de la santé publique du Canada de 2012-2013 à 2016-2017.
504 |aIncludes bibliographical references (pages 35-38).
520 |a"The purpose of this evaluation was to assess the relevance and performance of the Public Health Agency of Canada's (PHAC) healthcare-associated infection (HAI) activities. The evaluation covered guidance, surveillance, and outbreak response assistance activities provided by PHAC in relation to HAIs from April 2012 to September 2017. This first evaluation of HAI activities fulfills the requirements of the Treasury Board of Canada's Policy on Results (2016)"--Executive summary, page iv.
61020|aPublic Health Agency of Canada|xEvaluation.
650 0|aNosocomial infections|zCanada|xEvaluation.
650 0|aCommunicable diseases|zCanada|xPrevention|xEvaluation.
7102 |aPublic Health Agency of Canada. |bOffice of Audit and Evaluation, |eissuing body.
7101 |aCanada. |bHealth Canada. |bOffice of Audit and Evaluation, |eissuing body.
77508|tÉvaluation des activités visant les infections associées aux soins de santé à l'Agence de la santé publique du Canada de 2012-2013 à 2016-2017 / |w(CaOODSP)9.935356
85640|qPDF|s585 KB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/HP5-210-2018-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/corporate/transparency/corporate-management-reporting/evaluation/healthcare-associated-infection-activities-2012-2017.html